PARIS, Aug 6 (Reuters) - French laboratories and diagnostics company Eurofins EUFI.PA said it hoped to launch more products aimed at detecting the presence of the COVID-19 virus, as it posted higher first-half profits.
Net profits rose 60.9% from a year earlier to 95 million euros ($113 million). Revenues increased 7.2% to 2.323 billion euros and Eurofins said it was confident of meeting its 2020 financial targets, which include reaching 5 billion euros of revenues.
Eurofins has launched an array of products to detect the presence of SARS-CoV-2 virus responsible for the COVID-19 disease.
($1 = 0.8415 euros)
(Reporting by Sudip Kar-Gupta Editing by Shri Navaratnam)
((firstname.lastname@example.org; +33 1 49 49 53 84;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.